$5.6B
Venture capital deployed to Health Management Solutions in 2025, 18.8% of all global digital health funding.
Key Insights
- Operations & Workflow leads adoption: Healthcare operations is the primary entry point for AI, capturing the largest share of ventures and funding driven by measurable ROI and procurement readiness. Healthcare Operations & Workflow captures 49% of all Health Management Solutions ventures globally and 46% of health-system partnerships in the cluster.
- AI is now core infrastructure: AI-powered ventures captured $4.4B—representing 83% of all Health Management Solutions venture funding in 2025—supported by accelerating FDA clearances.
- Scaled platforms are pulling ahead: The market is rapidly consolidating; 25% of older ventures have exited, and M&A remains highly active as buyers seek enterprise-ready platforms. 21% of older ventures are inactive, M&A activity holds steady at 37–41 deals per year, and average deal size has tripled from $11.9M (Q1 2022) to $35.4M (Q1 2026).
- Regional strategies must diverge: North America dominates in scale, Europe differentiates through clinical intelligence, and Asia Pacific represents the fastest-growing greenfield opportunity. The United States hosts 41% of global ventures and recorded $4.5B of 2025 funding (1.8x YoY); Europe holds 23% with Clinical Decision Intelligence taking 47% of regional capital; Asia Pacific funding surged +87% YoY in 2025.
- Partnerships are fewer but deeper: Overall partnership volume declined as health systems shifted away from exploratory pilots in favour of enterprise-scale deployments with selected vendors. Partnership volume fell 25% from 846 in 2024 to 636 in 2025, while health-system partnerships specifically dropped from a 2024 peak of 247 to 165 — a clear signal of selective enterprise procurement.
Companies & Ventures Featured in the Report
Google Cloud, Microsoft, Oracle Cerner, Epic Systems, Menlo Ventures, General Catalyst, Bessemer Venture Partners, Flare Capital Partners, Andreessen Horowitz (a16z), F-Prime Capital, Chamber Cardio, House Rx, Qualified Health, Hippocratic AI, WellBeam, Aledade, Abridge, CMR Surgical, Airstrip Technologies, WHOOP, Harbinger Health, Universal Diagnostics, Midi Health, Zarminali Health.
Why You Need This Report
- Investors: Concentrate your capital strategically by identifying proven, late-stage AI-native platforms in a consolidating, winner-takes-most market where 83% of funding now flows to AI ventures.
- Corporates (Health Systems & Pharma): Learn how to successfully scale AI from isolated pilots to enterprise-wide deployments that deliver measurable ROI, alleviate severe workforce shortages, and build critical data infrastructure.
- Ventures: Discover why you must prove enterprise-readiness—by demonstrating real-world evidence, regulatory credibility, and deep workflow integration—or risk being locked out of health system procurement and future capital.
About the Data
The report is powered by HealthTech Alpha, The most trusted Digital Health actionable intelligence and insights platform for healthcare leaders. Leveraging an extensive database of over 16,000 ventures and cutting-edge analytics, HealthTech Alpha transforms fragmented information from over 30,000 sources into structured, traceable intelligence that supports screening, benchmarking, diligence, and monitoring.
Designed to empower stakeholders—including investors, pharmaceutical leaders, and medical device manufacturers—HealthTech Alpha offers actionable intelligence that can be integrated directly into your LLM tools to navigate digital transformation complexities, equipping you to identify strategic opportunities, assess market dynamics, and stay ahead in this fast-evolving industry.
